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Background: Genome-wide association study (GWAS) has identified that rs8050136 C/A polymorphism in fat mass
and obesity-associated gene (FTO) was associated with the risk of type 2 diabetes (T2D) in Europeans. But this
association was abolished after adjustment for body mass index (BMI), suggesting that the effect of rs8050136 on
T2D risk might be mediated by BMI in Europeans. However, the findings in subsequent studies were inconsistent
among Asian populations. To determine whether rs8050136 polymorphism in FTO is independently associated with
the risk of T2D in Chinese, we conducted a case–control study with 2,925 T2D patients and 3,281 controls in Han
Chinese.
Results: Logistic regression revealed that the A allele of rs8050136 was significantly associated with an increased risk of
T2D, independent of BMI (odds ratio (OR) = 1.17, 95% confidence interval (95% CI) = 1.03-1.32, p = 0.016). Meta-analysis
containing 10 reported studies and our data with a total of 15,819 cases and 18,314 controls further confirmed the
association between rs8050136 polymorphism and T2D risk in East Asians (OR = 1.13, 95% CI = 1.07-1.19).
Conclusions: Our findings indicate that the genetic variant in FTO may contribute to T2D risk in Han Chinese and
rs8050136 polymorphism may be a genetic marker for T2D susceptibility.
Keywords: Fat mass and obesity-associated Gene, Genome-wide association study, Genetic susceptibility, Single
nucleotide polymorphism, Type 2 diabetesBackground
Type 2 diabetes (T2D) is a major global health problem
with an increasing prevalence over the world [1]. More
than 60% of the world’s diabetes patients will be Asians
in 2025 [2]. In China, it has become an epidemic con-
cern due to the western lifestyle [3]. Although the eti-
ology of T2D has not been well elucidated, genetic and
environmental factors are considered to be involved in
its development [4].* Correspondence: wxqianyun111@sina.com; hbshen@njmu.edu.cn
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reproduction in any medium, provided the orIn 2007, genome-wide association studies (GWAS)
firstly reported that single nucleotide polymorphism
(SNP) rs8050136 in fat mass and obesity-associated gene
(FTO) was associated with the risk of T2D in European
populations [5,6]. However, this association was not
significant after adjustment for body mass index (BMI).
Another GWAS identified SNP rs9939609 in FTO as
strongly associated with both BMI and obesity in
Europeans [7]. Based on the public HapMap SNP
database, rs8050136 and rs9939609 were in the perfect
linkage disequilibrium (LD) (r2 = 1). Therefore, it is
suggested that the effect of rs8050136 or rs9939609 on
T2D risk may be mediated through a primary effect on
obesity in European populations.
Following the initial reports in populations of European
descent, Horikoshi et al. found that rs8050136 was also as-
sociated with T2D risk in a Japanese population, however,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Qian et al. BMC Genetics 2013, 14:86 Page 2 of 6
http://www.biomedcentral.com/1471-2156/14/86which was independent of BMI [8]. In contrast, Ng et al.
did not find a significant association in Hongkong and
Korean populations (OR = 1.09, 95% CI = 0.97-1.23) [9].
Among Chinese populations, the association between
rs8050136 and T2D risk failed to be replicated in Hu’s
study [10]; however, Han et al. detected a positive
association in another Chinese Han population [11]. To
determine whether rs8050136 polymorphism in FTO is
independently associated with the risk of T2D, we
conducted a case–control study with 2,925 T2D cases and
3,281 controls in Han Chinese. In addition, we also under-
took a systematic meta-analysis including 15,819 cases
and 18,314 controls to assess the association between this
FTO polymorphism and T2D risk in East Asians.Results
The distributions of demographic and selected clinical
characteristics of 2,925 T2D cases and 3,281 controls
were summarized in (Additional file 1: Table S1). No sig-
nificant differences were observed in the distributions of
sex, smoking and drinking status. Type 2 diabetes cases
were older than controls and had significantly higher
levels of BMI, fasting blood glucose (FBG), triglyceride
(TG), total cholesterol (TC), blood pressure and signifi-
cantly lower level of high-density lipoprotein cholesterol
(HDL-C). The genotype distribution of rs8050136 in FTO
and its association with T2D risk between the T2D cases
and controls were shown in Table 1. The observed geno-
type frequencies for rs8050136 were in Hardy–Weinberg
equilibrium (HWE) in the controls (p = 0.941). Significant
differences of genotype distribution between the T2D
cases and controls were observed for rs8050136 in the
dominant model (crude OR = 1.30, 95% CI = 1.15-1.46,
p = 3.0×10-5) and the additive model (crude OR = 1.27,
95% CI = 1.13-1.41, p = 3.8×10-5). With the adjustment
for age, sex and BMI in the logistic regression model,
rs8050136 CA/AA genotypes were associated with a sig-
nificantly increased risk of T2D (OR = 1.19, 95%
CI = 1.04-1.37, p = 0.011), as compared with CC genotype.
Similar association was also observed in the additive
model (adjusted OR = 1.17, 95% CI = 1.03-1.32,
p = 0.016).Table 1 The genotype distribution of rs8050136 and the asso
Genotype Cases N (%) Controls N (%) OR (
CC 2205 (76.1) 2625 (80.5) 1
CA 652 (22.5) 602 (18.5) 1.29(1
AA 41 (1.4) 35 (1.1) 1.39(0
CA/AA 693 (23.9) 637 (19.5) 1.30(1
Additive 1.27(1
Genotype was successfully detected in 2,898 T2D cases and 3,262 controls. Odds ra
regression model. Results of adjustment for age, sex and body mass index are in boWe then conducted the stratified analyses by age, sex
and BMI. As shown in Table 2, the associations between
rs8050136 polymorphism and T2D risk were also evi-
dent in the groups of elderly subjects (age > 56 years:
OR = 1.24, 95% CI = 1.05-1.46, p = 0.010), female sub-
jects (OR = 1.20, 95% CI = 1.02-1.40, p = 0.025) and
those with normal weight (BMI < 24 kg/m2: OR = 1.25,
95% CI = 1.07-1.46, p = 0.005). No heterogeneity was
observed among these subgroups.
A total of 10 published studies on the association be-
tween rs8050136 polymorphism and T2D risk in East
Asian populations were summarized in (Additional
file 2: Table S2) [8-17]. These 10 studies, together with
our present study, were included in the meta-analysis.
Overall meta-analysis results revealed that rs8050136 A
allele was associated with an increased T2D risk in East
Asians (OR = 1.13, 95% CI = 1.07-1.19, Figure 1).
Further meta-analysis also confirmed the association
with T2D risk in Chinese Hans (OR = 1.16, 95%
CI = 1.08-1.23) (Additional file 3: Figure S1). No obvious
heterogeneity was observed between the selected studies
(heterogeneity p = 0.430 and I2 = 1.2% for East Asians;
heterogeneity p = 0.569 and I2 = 0.0% for Chinese Hans).
Funnel plot and Egger’s test were used to address the
potential publication bias and no significant publication
bias was found (t = −0.71, p = 0.495 for East Asians,
Figure 2; t = −0.53, p = 0.617 for Chinese Hans,
Additional file 4: Figure S2).
Discussion
In this study, we investigated the association of rs8050
136 polymorphism in FTO with T2D risk in Han
Chinese. We found that rs8050136 A allele was signifi-
cantly associated with an increased T2D risk in Han
Chinese, which was further supported by a meta-analysis
containing 10 reported studies in East Asians and our
present study.
Although a number of studies have investigated the as-
sociation between FTO rs8050136 polymorphism and
T2D risk in Asian populations, the results were incon-
sistent. Horikoshi et al. reported a significant association
(OR = 1.22, 95% CI = 1.03-1.46, p = 0.025) between
rs8050136 and T2D risk in 864 cases and 864 controlsciation with type 2 diabetes risk in Han Chinese
95% CI) p-value OR (95% CI) p-value
.00 1.00
.14–1.46) 6.3×10-5 1.20(1.04–1.38) 0.011
.89–2.20) 0.152 1.11(0.66–1.87) 0.687
.15–1.46) 3.0×10-5 1.19(1.04–1.37) 0.011
.13–1.41) 3.8×10-5 1.17(1.03–1.32) 0.016
tios (95% confidence intervals) and p-values were calculated in the logistic
ld.
Table 2 The stratified analyses on the association between rs8050136 and the risk of type 2 diabetes
Variables Cases Controls OR (95% CI) p-value p-value
Age
≤56 863/246/15 1165/260/17 1.07(0.88–1.30) 0.484
0.258
>56 1341/406/26 1460/342/18 1.24(1.05–1.46) 0.010
Sex
females 1382/400/28 1641/372/23 1.20(1.02–1.40) 0.025
0.557
males 823/252/13 984/230/12 1.11(0.90–1.36) 0.350
BMI
normal 849/255/10 2107/471/28 1.25(1.07–1.46) 0.005
0.663overweight 945/255/18 438/111/5 1.10(0.88–1.39) 0.391
obesity 394/137/12 74/20/2 1.19(0.75–1.89) 0.454
Listed are the counts of CC/CA/AA genotypes in T2D cases and controls. Odds ratios (95% confidence intervals) and p-values were calculated in the logistic
regression model with adjustment for age, sex and body mass index where appropriate. P-value in bold is for the heterogeneity test based on chi-squared based
Q test.
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comprising 1,912 cases and 2,041 controls in a Han
Chinese population (OR = 1.22, 95% CI= 1.05-1.41,
p = 0.008) [14]. However, Omori et al. were not able to
replicate the association (OR = 1.09, 95% CI = 0.91-1.30,
p = 0.350) in a case–control study with 1,630 T2D cases
and 1,064 controls in Japanese [12]. In the present study,
we observed the significant association between
rs8050136 and T2D risk (OR = 1.17, 95% CI = 1.03-1.32,
p = 0.016) after adjustment for age, sex and BMI. The
discrepancy of the association of rs8050136 with T2D
risk in East Asians may be due to the relatively low fre-
quency (minor allele frequencies (MAFs) = 0.12 and
0.17 for Chinese and Japanese populations) leading to a
low statistical power, as compared with the populations


























Figure 1 Meta-analysis of the association between rs8050136 polymo
effect size of SNP rs8050136 on T2D risk in East Asians, a meta-analysis incl
polymorphism and T2D risk in East Asians and our present study was cond
and I2=1.2%). The pooled OR for SNP rs8050136 and the risk of T2D was siganalysis conducted in this study may represent a powerful
approach to clarify the relationship between rs8050136
and T2D risk by pooling 15,819 cases and 18,314 controls
and confirm this association in East Asians.
Our study showed the A allele of rs8050136 was
significantly associated with an increased risk of T2D,
independent of BMI. A recent meta-analysis including
96,551 East and South Asians reported that the minor
allele for the rs9939609 FTO SNP (perfect LD with
rs8050136) significantly increased the risk of both obes-
ity and T2D, and the association between the FTO locus
and risk of T2D remained significant after adjustment
for BMI [18]. Interestingly, a recent meta-analysis of
41,504 Scandinavians revealed that the significant associ-
ation for rs9939609 with the risk of T2D also remained



























rphism and the risk of T2D in East Asians. To estimate the pooled
uding 10 published studies on the association between rs8050136
ucted. There was no heterogeneity of ORs across studies (p = 0.430
nificant (pooled OR = 1.13, 95% CI = 1.07-1.19) in East Asians.
log[OR]
SE of log[OR]




1 Egger’s test t = -0.71 p = 0.495
Figure 2 Funnel plot analysis to detect the publication bias in
East Asians. The funnel plot was symmetrical and the result from
Egger’s test was non-significant (t = −0.71, p = 0.495).
Qian et al. BMC Genetics 2013, 14:86 Page 4 of 6
http://www.biomedcentral.com/1471-2156/14/86consistent with those of the earlier study that showed
the association of rs8050136 with T2D risk was mediated
through BMI among Europeans [6].
The SNP rs8050136 is mapped to the intron 1 of FTO
gene on chromosome 16. The exact function of the gene
product of FTO is not yet understood and how the poly-
morphism affects the risk of T2D is unclear. Based on
sequence homology, FTO gene is predicted to encode a
2-oxoglutarate-dependent demethylase enzyme, which
affects nucleic acid demethylation [20]. This gene may
be critical in epigenetic regulation of the progress of
T2D. Recently, Bravard et al. found a significant increase
of FTO mRNA and protein in skeletal muscle of T2D
patients, suggesting that FTO may involve in T2D
pathogenesis through oxidative metabolism, lipogenesis
and oxidative stress in muscle defects [21].
The limitation of this case–control study was that
most of the T2D cases were diagnosed before the sur-
veys and therefore, their BMI may not be a perfect
measure of adiposity, particularly in lean individuals and
in East Asians who usually have more abdominal fat and
less muscle mass than Caucasians. Although we adjusted
BMI for adiposity in detecting the association of FTO
polymorphism with T2D risk, we cannot rule out the
possibility of residual confounding of obesity, because
the alternative measures (such as DEXA fat mass) of
adiposity were not available in this study. More alterna-
tive measures of adiposity need to be considered in
future studies.
Conclusions
In summary, we evaluated the association of FTO
rs8050136 polymorphism with the risk of T2D in a large
case–control study and 2 meta-analyses and confirmed
that the A allele was significantly associated with an in-
creased risk of T2D in East Asians. Further studies are
warranted to clarify the potentially biological mechanisms
of FTO rs8050136 polymorphism in T2D pathogenesis.Methods
Study subjects
All subjects were genetically unrelated ethnic Han
Chinese and the study population was previously de-
scribed [22,23]. In brief, 2,925 T2D cases and 3,281 con-
trols were recruited from 2 community-based chronic
non-communicable disease surveys in Jiangsu province,
from 2004 to 2008. Subjects were considered to have
T2D if they had a history of T2D or if their fasting
glucose was 7.0 mmol/l or higher. Those without history
of diabetes, hypertension, coronary heart disease, stroke,
cancer and with fasting glucose < 5.6 mmol/l were
selected as controls from the same population and
frequency-matched to the cases by age, sex and residen-
tial area. All participants were interviewed by trained in-
terviewers to obtain information on demographic data,
smoking, alcohol drinking, family history, physical activ-
ity and disease history using standard questionnaires. At
the same time, anthropometrical measurements were
performed. A 5 ml blood sample was collected from
each subject after fasting for more than 8 hours. FBG
and lipid levels, including TC, TG, and HDL-C were
detected in standard methods. According to the criteria
proposed by the Working Group on Obesity in China,
we defined overweight as 24 kg/m2 ≤ BMI < 28 kg/m2,
and obesity as BMI ≥ 28 kg/m2 [24]. The distributions of
demographic and clinical characteristics of the T2D
cases and controls were summarized in (Additional
file 1: Table S1). This study was approved by the institu-
tional review board of Nanjing Medical University.
Written informed consent was obtained from each
participant.
Genotyping assay
Genomic DNA was isolated from leukocyte pellets of ven-
ous blood by proteinase K digestion, followed by phenol-
chloroform extraction. TaqMan OpenArray Genotyping
System (Life Technologies, Carlsbad, CA, USA) and the
iPLEX Sequenom MassARRAY platform (Sequenom, Inc.,
San Diego, CA, USA) were used to perform genotyping.
Genotype was successfully detected in 2,898 cases and
3,262 controls, with the call rate being 99.2%. Genotyping
was performed by technicians without knowing the sta-
tuses of T2D cases or controls. Two blank controls in each
plate were used for quality control. 96 randomly selected
duplicated samples were examined on two platforms and
the concordant rate was 100%.
Meta-analysis
We searched all case–control studies on the association
between FTO gene rs8050136 polymorphism and T2D
risk in East Asian populations. Eligible studies, published
in English, up to August, 2012, were identified by using
the search terms “FTO and polymorphism and type 2
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in East Asians were excluded in manual. ORs and 95%
CIs were calculated in additive model after adjustment
in logistic regression. Cochran’s χ2-based Q-statistic test
was performed to assess the heterogeneity among the
included studies. The combined OR was calculated using
the Mantel–Haenszel method in fixed-effect model with
95% CI in Woolf ’s method as there was no significant
heterogeneity. Publication bias was evaluated with
Egger’s t test.
Statistical analyses
The differences in demographic variables, selected vari-
ables, and frequencies of the genotypes between cases
and controls were evaluated by using the Student’s t-test
for continuous variables and the χ2 - test for categorical
variables. The Hardy-Weinberg equilibrium was tested
by a goodness-of-fit χ2 - test in controls. The association
between SNP and T2D risk was estimated by computing
the ORs and 95% CIs using unconditional logistic re-
gression analysis after adjustment for age, sex and BMI.
Heterogeneity test for stratified analyses of the selected
variables was conducted with the χ2-based Q test. Multi-
variate linear regression analyses were performed to test
the correlation between the genotypes and quantitative
BMI trait after adjustment for age and sex. The statis-
tical power was calculated by PS (power and sample size
calculation) 3.0.2 software. All statistical analyses were
performed by using STATA version 11.0 (StataCorp LP,
College Station, TX, USA).
Additional files
Additional file 1: Table S1. General characteristics of type 2 diabetes
cases and controls. This table shows the characteristics of the study
population. No significant differences were observed in the distributions
of sex, smoking and drinking status. Type 2 diabetes cases were older
than controls and had significantly higher levels of body mass index,
fasting blood glucose, triglyceride, total cholesterol, blood pressure and
significantly lower level of high-density lipoprotein cholesterol.
Additional file 2: Table S2. Published studies on the association
between rs8050136 polymorphism and the risk of type 2 diabetes in East
Asians. The table displays minor allele frequencies (MAFs), sample sizes,
adjusted odds ratios (ORs) and 95% confidence intervals (CIs), p-values,
populations, journals, authors and published year of the 10 published
studies among East Asian populations. They were included in the meta-
analyses together with the present study.
Additional file 3: Figure S1. Meta-analysis of the association of
rs8050136 polymorphism with the risk of type 2 diabetes in Han Chinese.
The figure shows the results of the meta-analysis covering 6 reported
studies in Chinese Han populations and our present study.
Additional file 4: Figure S2. Funnel plot analysis to detect the
publication bias in Chinese Han populations. The figure shows the results
of the funnel plot analysis to address the potential publication bias about
the 7 studies conducted among Chinese Han populations.
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